Search research articles
Contact Us
Filters
Showing results (111-120 of 163) with videos related to
Page
of 17
Sort By:
Frontiers in Medicine
|
September 12, 2022
Effect of atorvastatin on skeletal muscles of patients with knee osteoarthritis: <i>Post-hoc</i> analysis of a randomised controlled trial
Yuan Z Lim, Flavia M Cicuttini, Anita E Wluka, et al.
BMC Neurology
|
February 10, 2012
Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion)
Christopher M Reid, Elsdon Storey, Tien Y Wong, et al.
Cardiovascular Therapeutics
|
August 18, 2015
The Effect of a Cardiovascular Polypill Strategy on Pill Burden
Michael Truelove, Anushka Patel, Severine Bompoint, et al.
Circulation
|
March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
R John Simes, Ian C Marschner, David Hunt, et al.
Journal of the American College of Cardiology
|
October 22, 2013
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)
Harvey D White, Andrew Tonkin, John Simes, et al.
Circulation
|
September 15, 2004
Effect of pravastatin on cardiovascular events in people with chronic kidney disease
Marcello Tonelli, Chris Isles, Gary C Curhan, et al.
Journal of the American College of Cardiology
|
May 6, 2014
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium?
Harvey D White, Andrew Tonkin, John Simes, et al.
International Journal of Cardiology
|
July 22, 2017
Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction model
Andrea Driscoll, Elizabeth H Barnes, Stefan Blankenberg, et al.
Circulation
|
November 4, 2024
Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis
Harpreet S Bhatia, Simon Wandel, Peter Willeit, et al.
International Journal of Cardiology
|
May 6, 2021
Risk stratification of cardiovascular complications using CHA<sub>2</sub>DS<sub>2</sub>-VASc and CHADS<sub>2</sub> scores in chronic atherosclerotic cardiovascular disease
Jonathan Sen, Andrew Tonkin, John Varigos, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 163) with videos related to
Sort By:
Page
of 17
Frontiers in Medicine
|
September 12, 2022
Effect of atorvastatin on skeletal muscles of patients with knee osteoarthritis: <i>Post-hoc</i> analysis of a randomised controlled trial
Yuan Z Lim, Flavia M Cicuttini, Anita E Wluka, et al.
BMC Neurology
|
February 10, 2012
Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion)
Christopher M Reid, Elsdon Storey, Tien Y Wong, et al.
Cardiovascular Therapeutics
|
August 18, 2015
The Effect of a Cardiovascular Polypill Strategy on Pill Burden
Michael Truelove, Anushka Patel, Severine Bompoint, et al.
Circulation
|
March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
R John Simes, Ian C Marschner, David Hunt, et al.
Journal of the American College of Cardiology
|
October 22, 2013
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)
Harvey D White, Andrew Tonkin, John Simes, et al.
Circulation
|
September 15, 2004
Effect of pravastatin on cardiovascular events in people with chronic kidney disease
Marcello Tonelli, Chris Isles, Gary C Curhan, et al.
Journal of the American College of Cardiology
|
May 6, 2014
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium?
Harvey D White, Andrew Tonkin, John Simes, et al.
International Journal of Cardiology
|
July 22, 2017
Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction model
Andrea Driscoll, Elizabeth H Barnes, Stefan Blankenberg, et al.
Circulation
|
November 4, 2024
Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis
Harpreet S Bhatia, Simon Wandel, Peter Willeit, et al.
International Journal of Cardiology
|
May 6, 2021
Risk stratification of cardiovascular complications using CHA<sub>2</sub>DS<sub>2</sub>-VASc and CHADS<sub>2</sub> scores in chronic atherosclerotic cardiovascular disease
Jonathan Sen, Andrew Tonkin, John Varigos, et al.
Page
of 17